O	0	14	Overexpression	Overexpression	NN	B-NP
O	15	17	of	of	IN	B-PP
O	18	22	Glut	Glut	NN	B-NP
O	22	23	-	-	HYPH	B-NP
O	23	24	1	1	CD	I-NP
O	25	32	glucose	glucose	NN	I-NP
O	33	44	transporter	transporter	NN	I-NP
O	45	47	in	in	IN	B-PP
O	48	53	human	human	JJ	B-NP
B-Cancer	54	60	breast	breast	NN	I-NP
I-Cancer	61	67	cancer	cancer	NN	I-NP
O	67	68	.	.	.	O

O	69	71	An	An	DT	B-NP
O	72	91	immunohistochemical	immunohistochemical	JJ	I-NP
O	92	97	study	study	NN	I-NP
O	97	98	.	.	.	O

O	99	109	BACKGROUND	BACKGROUND	NN	B-NP
O	109	110	:	:	:	O
B-Cancer	111	117	Breast	Breast	NN	B-NP
I-Cancer	118	125	cancers	cancer	NNS	I-NP
O	126	130	have	have	VBP	B-VP
O	131	137	higher	high	JJR	B-ADJP
O	138	142	than	than	IN	B-PP
O	143	149	normal	normal	JJ	B-NP
O	150	157	glucose	glucose	NN	I-NP
O	158	168	metabolism	metabolism	NN	I-NP
O	168	169	,	,	,	O
O	170	173	but	but	CC	O
O	174	177	the	the	DT	B-NP
O	178	187	mechanism	mechanism	NN	I-NP
O	188	190	of	of	IN	B-PP
O	191	198	glucose	glucose	NN	B-NP
O	199	204	entry	entry	NN	I-NP
O	205	209	into	into	IN	B-PP
O	210	215	these	these	DT	B-NP
B-Cancer	216	222	tumors	tumor	NNS	I-NP
O	223	225	is	be	VBZ	B-VP
O	226	229	not	not	RB	O
O	230	234	well	well	RB	B-ADJP
O	235	245	understood	understand	VBN	I-ADJP
O	245	246	.	.	.	O

O	247	254	METHODS	METHODS	NNS	B-NP
O	254	255	:	:	:	O
O	256	259	The	The	DT	B-NP
O	260	270	expression	expression	NN	I-NP
O	271	273	of	of	IN	B-PP
O	274	278	five	five	CD	B-NP
O	279	291	facilitative	facilitative	JJ	I-NP
O	292	299	glucose	glucose	NN	I-NP
O	300	312	transporters	transporter	NNS	I-NP
O	312	313	,	,	,	O
O	314	318	Glut	Glut	NN	B-NP
O	318	319	-	-	HYPH	B-NP
O	319	320	1	1	CD	I-NP
O	321	322	(	(	(	O
B-Cell	322	333	erythrocyte	erythrocyte	NN	B-NP
O	334	338	type	type	NN	I-NP
O	338	339	)	)	)	O
O	339	340	,	,	,	O
O	341	345	Glut	Glut	NN	B-NP
O	345	346	-	-	HYPH	B-NP
O	346	347	2	2	CD	I-NP
O	348	349	(	(	NN	I-NP
B-Organ	349	354	liver	liver	NN	I-NP
O	355	359	type	type	NN	I-NP
O	359	360	)	)	)	O
O	360	361	,	,	,	O
O	362	366	Glut	Glut	NN	B-NP
O	366	367	-	-	HYPH	B-NP
O	367	368	3	3	CD	I-NP
O	369	370	(	(	NN	I-NP
B-Organ	370	375	brain	brain	NN	I-NP
O	376	380	type	type	NN	I-NP
O	380	381	)	)	)	O
O	381	382	,	,	,	O
O	383	387	Glut	Glut	NN	B-NP
O	387	388	-	-	HYPH	O
O	388	389	4	4	CD	B-NP
O	390	391	(	(	(	O
B-Organ	391	397	muscle	muscle	NN	B-NP
O	397	398	/	/	SYM	O
B-Tissue	398	401	fat	fat	NN	B-NP
O	402	406	type	type	NN	I-NP
O	406	407	)	)	)	O
O	407	408	,	,	,	O
O	409	412	and	and	CC	O
O	413	417	Glut	Glut	NN	B-NP
O	417	418	-	-	HYPH	O
O	418	419	5	5	CD	B-NP
O	420	421	(	(	(	O
B-Organ	421	426	small	small	JJ	B-NP
I-Organ	427	436	intestine	intestine	NN	I-NP
O	437	441	type	type	NN	I-NP
O	441	442	)	)	)	O
O	442	443	,	,	,	O
O	444	447	was	be	VBD	B-VP
O	448	455	studied	study	VBN	I-VP
O	456	458	by	by	IN	B-PP
O	459	479	immunohistochemistry	immunohistochemistry	NN	B-NP
O	480	482	of	of	IN	B-PP
B-Cancer	483	491	paraffin	paraffin	NN	B-NP
I-Cancer	492	500	sections	section	NNS	I-NP
O	501	505	from	from	IN	B-PP
O	506	508	12	12	CD	B-NP
B-Cancer	509	516	primary	primary	JJ	I-NP
I-Cancer	517	522	human	human	JJ	I-NP
I-Cancer	523	529	breast	breast	NN	I-NP
I-Cancer	530	537	cancers	cancer	NNS	I-NP
O	538	541	and	and	CC	O
O	542	543	8	8	CD	B-NP
B-Cancer	544	549	lymph	lymph	NN	I-NP
I-Cancer	550	554	node	node	NN	I-NP
I-Cancer	555	565	metastases	metastasis	NNS	I-NP
O	566	570	from	from	IN	B-PP
O	571	572	2	2	CD	B-NP
O	573	581	patients	patient	NNS	I-NP
O	581	582	.	.	.	O

O	583	586	Rat	Rat	NN	B-NP
B-Tissue	587	594	tissues	tissue	NNS	I-NP
O	595	600	known	know	VBN	B-VP
O	601	603	to	to	TO	B-VP
O	604	611	express	express	VB	I-VP
O	612	617	these	these	DT	B-NP
O	618	625	glucose	glucose	NN	I-NP
O	626	638	transporters	transporter	NNS	I-NP
O	639	643	were	be	VBD	B-VP
O	644	648	used	use	VBN	I-VP
O	649	651	as	as	IN	B-PP
O	652	660	controls	control	NNS	B-NP
O	660	661	.	.	.	O

O	662	669	RESULTS	RESULTS	NNS	B-NP
O	669	670	:	:	:	O
O	671	674	All	All	PDT	B-NP
O	675	678	the	the	DT	I-NP
B-Cancer	679	686	primary	primary	JJ	I-NP
I-Cancer	687	693	breast	breast	NN	I-NP
I-Cancer	694	701	cancers	cancer	NNS	I-NP
O	702	705	and	and	CC	O
O	706	709	the	the	DT	B-NP
B-Cancer	710	715	lymph	lymph	NN	I-NP
I-Cancer	716	720	node	node	NN	I-NP
I-Cancer	721	731	metastases	metastasis	NNS	I-NP
O	732	736	were	be	VBD	B-VP
O	737	745	positive	positive	JJ	B-ADJP
O	746	749	for	for	IN	B-PP
O	750	754	Glut	Glut	NNP	B-NP
O	754	755	-	-	HYPH	B-NP
O	755	756	1	1	CD	I-NP
O	756	757	.	.	.	O

O	758	762	This	This	DT	B-NP
O	763	774	transporter	transporter	NN	I-NP
O	775	778	was	be	VBD	B-VP
O	779	788	expressed	express	VBN	I-VP
O	789	791	on	on	IN	B-PP
O	792	795	the	the	DT	B-NP
B-Cellular_component	796	800	cell	cell	NN	I-NP
I-Cellular_component	801	809	membrane	membrane	NN	I-NP
O	810	813	and	and	CC	B-PP
O	814	816	in	in	IN	B-PP
O	817	820	the	the	DT	B-NP
B-Organism_substance	821	830	cytoplasm	cytoplasm	NN	I-NP
O	831	833	of	of	IN	B-PP
O	834	837	the	the	DT	B-NP
B-Cell	838	843	tumor	tumor	NN	I-NP
I-Cell	844	849	cells	cell	NNS	I-NP
O	849	850	,	,	,	O
O	851	854	but	but	CC	O
O	855	864	exhibited	exhibit	VBD	B-VP
O	865	871	marked	marked	JJ	B-NP
B-Cancer	872	884	intratumoral	intratumoral	JJ	I-NP
O	885	888	and	and	CC	I-NP
B-Cancer	889	901	intertumoral	intertumoral	JJ	I-NP
O	902	913	variability	variability	NN	I-NP
O	914	916	in	in	IN	B-PP
O	917	920	the	the	DT	B-NP
O	921	932	proportions	proportion	NNS	I-NP
O	933	935	of	of	IN	B-PP
O	936	944	positive	positive	JJ	B-NP
B-Cell	945	950	cells	cell	NNS	I-NP
O	951	954	and	and	CC	O
O	955	958	the	the	DT	B-NP
O	959	968	intensity	intensity	NN	I-NP
O	969	971	of	of	IN	B-PP
O	972	980	staining	staining	NN	B-NP
O	980	981	.	.	.	O

O	982	990	Staining	Staining	NN	B-NP
O	991	993	of	of	IN	B-PP
O	994	997	the	the	DT	B-NP
O	998	1004	normal	normal	JJ	I-NP
B-Tissue	1005	1012	mammary	mammary	JJ	I-NP
I-Tissue	1013	1023	epithelium	epithelium	NN	I-NP
O	1023	1024	,	,	,	O
O	1025	1027	if	if	IN	B-SBAR
O	1028	1035	present	present	NN	B-NP
O	1035	1036	,	,	,	O
O	1037	1040	was	be	VBD	B-VP
O	1041	1045	much	much	RB	B-ADJP
O	1046	1051	lower	low	JJR	I-ADJP
O	1052	1056	than	than	IN	B-SBAR
O	1057	1065	observed	observe	VBN	B-VP
O	1066	1068	in	in	IN	B-PP
B-Cell	1069	1074	tumor	tumor	NN	B-NP
I-Cell	1075	1080	cells	cell	NNS	I-NP
O	1081	1085	from	from	IN	B-PP
O	1086	1089	the	the	DT	B-NP
O	1090	1094	same	same	JJ	I-NP
O	1095	1102	patient	patient	NN	I-NP
O	1102	1103	.	.	.	O

O	1104	1108	Glut	Glut	NN	B-NP
O	1108	1109	-	-	HYPH	O
O	1109	1110	2	2	CD	B-NP
O	1111	1114	was	be	VBD	B-VP
O	1115	1124	expressed	express	VBN	I-VP
O	1125	1127	in	in	IN	B-PP
O	1128	1131	all	all	DT	B-NP
O	1132	1134	of	of	IN	B-PP
O	1135	1138	the	the	DT	B-NP
B-Cancer	1139	1145	tumors	tumor	NNS	I-NP
O	1145	1146	,	,	,	O
O	1147	1150	but	but	CC	O
O	1151	1154	the	the	DT	B-NP
O	1155	1164	intensity	intensity	NN	I-NP
O	1165	1167	of	of	IN	B-PP
O	1168	1176	staining	staining	NN	B-NP
O	1177	1180	was	be	VBD	B-VP
O	1181	1184	not	not	RB	O
O	1185	1197	consistently	consistently	RB	B-ADJP
O	1198	1206	stronger	strong	JJR	I-ADJP
O	1207	1211	than	than	IN	B-PP
O	1212	1216	that	that	DT	B-NP
O	1217	1221	seen	see	VBN	B-VP
O	1222	1224	in	in	IN	B-PP
B-Tissue	1225	1232	healthy	healthy	JJ	B-NP
I-Tissue	1233	1239	breast	breast	NN	I-NP
O	1239	1240	.	.	.	O

O	1241	1249	Clusters	Cluster	NNS	B-NP
O	1250	1252	of	of	IN	B-PP
O	1253	1257	Glut	Glut	NN	B-NP
O	1257	1258	-	-	HYPH	B-NP
O	1258	1259	4	4	CD	I-NP
O	1259	1260	-	-	HYPH	I-NP
O	1260	1268	positive	positive	JJ	I-NP
O	1269	1276	granule	granule	NN	I-NP
O	1277	1281	were	be	VBD	B-VP
O	1282	1290	observed	observe	VBN	I-VP
O	1291	1293	in	in	IN	B-PP
B-Cell	1294	1299	cells	cell	NNS	B-NP
O	1300	1302	in	in	IN	B-PP
O	1303	1306	six	six	CD	B-NP
O	1307	1309	of	of	IN	B-PP
O	1310	1313	the	the	DT	B-NP
B-Cancer	1314	1320	tumors	tumor	NNS	I-NP
O	1320	1321	.	.	.	O

O	1322	1326	None	None	NN	B-NP
O	1327	1329	of	of	IN	B-PP
O	1330	1333	the	the	DT	B-NP
B-Cancer	1334	1340	tumors	tumor	NNS	I-NP
O	1341	1343	or	or	CC	O
O	1344	1347	the	the	DT	B-NP
B-Tissue	1348	1355	healthy	healthy	JJ	I-NP
I-Tissue	1356	1362	breast	breast	NN	I-NP
O	1363	1365	in	in	IN	B-PP
O	1366	1369	the	the	DT	B-NP
B-Tissue	1370	1377	tissues	tissue	NNS	I-NP
O	1378	1385	studied	study	VBN	B-VP
O	1386	1395	expressed	express	VBD	B-VP
O	1396	1400	Glut	Glut	NN	B-NP
O	1400	1401	-	-	HYPH	B-NP
O	1401	1402	3	3	CD	I-NP
O	1403	1405	or	or	CC	I-NP
O	1406	1410	Glut	Glut	NN	I-NP
O	1410	1411	-	-	HYPH	B-NP
O	1411	1412	5	5	CD	I-NP
O	1412	1413	.	.	.	O

O	1414	1425	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	1425	1426	:	:	:	O
O	1427	1433	Higher	High	JJR	B-NP
O	1434	1444	expression	expression	NN	I-NP
O	1445	1447	of	of	IN	B-PP
O	1448	1451	the	the	DT	B-NP
O	1452	1459	glucose	glucose	NN	I-NP
O	1460	1471	transporter	transporter	NN	I-NP
O	1472	1476	Glut	Glut	NN	I-NP
O	1476	1477	-	-	HYPH	B-NP
O	1477	1478	1	1	CD	I-NP
O	1479	1481	by	by	IN	B-PP
B-Cell	1482	1488	breast	breast	NN	B-NP
I-Cell	1489	1495	cancer	cancer	NN	I-NP
I-Cell	1496	1501	cells	cell	NNS	I-NP
O	1502	1510	compared	compare	VBN	B-PP
O	1511	1515	with	with	IN	B-PP
O	1516	1519	the	the	DT	B-NP
B-Tissue	1520	1527	healthy	healthy	JJ	I-NP
I-Tissue	1528	1534	breast	breast	NN	I-NP
I-Tissue	1535	1541	tissue	tissue	NN	I-NP
O	1542	1544	is	be	VBZ	B-VP
O	1545	1551	common	common	JJ	B-ADJP
O	1551	1552	.	.	.	O

O	1553	1562	Increased	Increase	VBN	B-NP
O	1563	1570	glucose	glucose	NN	I-NP
O	1571	1582	transporter	transporter	NN	I-NP
O	1583	1590	protein	protein	NN	I-NP
O	1591	1601	expression	expression	NN	I-NP
O	1602	1605	may	may	MD	B-VP
O	1606	1616	contribute	contribute	VB	I-VP
O	1617	1619	to	to	TO	B-PP
O	1620	1623	the	the	DT	B-NP
O	1624	1633	increased	increase	VBN	I-NP
O	1634	1640	uptake	uptake	NN	I-NP
O	1641	1643	of	of	IN	B-PP
O	1644	1645	2	2	CD	B-NP
O	1645	1646	-	-	HYPH	I-NP
O	1646	1647	[	[	(	I-NP
O	1647	1650	18F	18F	NN	I-NP
O	1650	1651	]	]	)	O
O	1651	1652	-	-	HYPH	O
O	1652	1658	fluoro	fluoro	AFX	O
O	1658	1659	-	-	HYPH	B-NP
O	1659	1660	2	2	CD	I-NP
O	1660	1661	-	-	HYPH	I-NP
O	1661	1666	deoxy	deoxy	NN	I-NP
O	1666	1667	-	-	HYPH	B-NP
O	1667	1668	D	D	NN	I-NP
O	1668	1669	-	-	HYPH	O
O	1669	1676	glucose	glucose	NN	B-NP
O	1677	1678	(	(	(	O
O	1678	1681	FDG	FDG	NN	B-NP
O	1681	1682	)	)	)	O
O	1683	1685	by	by	IN	B-PP
O	1686	1691	these	these	DT	B-NP
B-Cancer	1692	1698	tumors	tumor	NNS	I-NP
O	1699	1707	observed	observe	VBN	B-VP
O	1708	1710	by	by	IN	B-PP
O	1711	1719	positron	positron	NN	B-NP
O	1720	1728	emission	emission	NN	I-NP
O	1729	1739	tomography	tomography	NN	I-NP
O	1740	1741	(	(	(	O
O	1741	1744	PET	PET	NN	B-NP
O	1744	1745	)	)	)	O
O	1746	1753	imaging	imaging	NN	B-NP
O	1753	1754	.	.	.	O

